Topical podofilox for the treatment of condylomata acuminata in women.

Obstet Gynecol

Department of Obstetrics and Gynecology, SUNY, Stony Brook 11794.

Published: October 1990

The purpose of this study was to determine the efficacy and safety of 0.5% podofilox solution (Condylox) for the treatment of genital warts in women. Thirty-seven women with anogenital warts applied the solution to the surface of these warts twice daily for 3 days, followed by 4 drug-free days. A minimum of two and a maximum of four treatment cycles were given. The subjects were evaluated weekly for the first 4 weeks and again at 6 and 10 weeks. At the end of 10 weeks, the mean number of warts per patient was reduced from 6.27 to 1.1, and half of the patients were completely cleared of warts. Only eight of 37 subjects (21.6%) developed new warts during the study period. Approximately 15% of patients reported "severe" local reactions to the treatment after the first treatment cycle, but this was reduced to only 5% by the last treatment cycle. During the same period, the patients reporting no side effects increased from 44 to 86%. The only woman who discontinued the study did so because of dizziness and epigastric discomfort, probably unrelated to drug use. Thus, 0.5% podofilox solution appears to be an effective treatment for condylomata acuminata, with acceptable side effects that are local and temporary.

Download full-text PDF

Source

Publication Analysis

Top Keywords

treatment condylomata
8
condylomata acuminata
8
05% podofilox
8
podofilox solution
8
weeks weeks
8
treatment cycle
8
side effects
8
treatment
7
warts
6
topical podofilox
4

Similar Publications

Human papillomavirus (HPV) infections rank as the most prevalent sexually transmitted infections globally. The Brazilian Ministry of Health recommends the topical use of 70%-90% trichloroacetic acid (TAA) for treating condyloma acuminata, yet this method suffers from a high recurrence rate of 36% and requires roughly six applications. Topical photodynamic therapy (PDT) has shown effectiveness in targeting subclinical lesions, but it also necessitates multiple sessions for complete lesion clearance.

View Article and Find Full Text PDF
Article Synopsis
  • Viral infections, such as plantar warts and herpes labialis, are prevalent among young competitive swimmers, with a study examining 1,047 swimmers in Greek clubs revealing significant correlations with age and years of training.
  • The study found that outdoor practice environments led to higher infection rates, and specific behaviors like walking barefoot and sharing equipment were linked to increased risks of herpes simplex and plantar warts.
  • Effective prevention strategies, including proper hygiene and medical guidance, are crucial to minimizing the impact of these infections on swimmers' health and performance.
View Article and Find Full Text PDF

Warts, benign epidermal proliferations, are a direct result of human papillomavirus (HPV) infection, specifically targeting the keratinocytes within the stratum corneum of the skin. The development of warts is the most common clinical manifestation of HPV, with plantar warts, condylomata acuminata, and common warts being the most frequently observed types. These growths can be unsightly and sometimes painful, affecting the quality of life for those afflicted.

View Article and Find Full Text PDF

In this cohort study a total of 203 women with genital warts, who were referred to gynecology clinic of Shahid Muftah in Yasuj city between 2019 and 2022, were examined and treated by a gynecologist and trained for injection of three doses of Gardasil vaccine after treatment. Of these, 138 women completed the study. Half of them who received three doses of the Gardasil vaccine, aligned in vaccinated group and the other half served as the unvaccinated group.

View Article and Find Full Text PDF

Human papillomavirus-associated cancers, precancers, and genital warts in Denmark, 2000-2022 - Current burden of disease and population impact of multi-cohort HPV vaccination.

Prev Med

December 2024

Unit of Virus, Lifestyle and Genes, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen O, Denmark; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark; Department of Gynecology, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen O, Denmark. Electronic address:

Article Synopsis
  • The study analyzed cancer trends related to human papillomavirus (HPV) in Denmark from 2000 to 2022, focusing on cervical precancer, genital warts, and overall disease burden post-HPV vaccination.
  • Findings revealed a significant decline in age-standardized incidence rates (ASRs) for cervical precancer and genital warts, particularly among women, while HPV-associated cancers have been rising in men and non-cervical sites among women.
  • The conclusion emphasized that, even with vaccination efforts leading to decreased cases of certain HPV-related conditions, HPV-associated diseases continue to pose a public health challenge, especially among men.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!